Mast Therapeutics, Inc. 4
4 · Mast Therapeutics, Inc. · Filed Jan 2, 2015
Insider Transaction Report
Form 4
Gorgas Gregory D.
Senior VP, Commercial
Transactions
- Award
Stock Option (Right to Buy)
2015-01-02+622,800→ 622,800 totalExercise: $0.58Exp: 2025-01-02→ Common Stock (622,800 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 substantially equal monthly installments on each monthly anniversary of January 2, 2015, subject to the reporting person's continued service.